Standards and Guidelines
Visiopharm and Boston Cell Standards Partnership: Solution combining first AI-Driven IHC Levey-Jennings software with first quantitative IHC reference materials will enable labs to meet proposed regulatory changes COPENHAGEN, Denmark &...
Visiopharm has announced preregistration for their USCAP 2022 seminar. AI-driven stain quality standardization of IHC Featuring Marilyn M. Bui, MD, Ph.D., Moffitt Cancer Center and Martin Kristensson, Visiopharm Wednesday, March 23rd,...
Tampa, Florida / GlobeNewswire – Digital pathology and cancer informatics provider Inspirata announced today that it has received U.S. Food and Drug Administration (FDA) clearance for its Dynamyx digital pathology software. This clearance...
Visiopharm, a world leader in AI-driven precision pathology software, today announced that its existing portfolio of diagnostic apps have all been certified under the new In Vitro Diagnostic Regulation (IVDR). The major difference between...
February 2, 2022 -- Artemis DNA’s two facilities, in Irvine, California and Houston, Texas, are now both CLIA and CAP accredited. Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high...
The four-year agreement is estimated to be worth £5 billion. A pool of 46 tech suppliers have been selected for the framework which provides digital document management tools and printing services to NHS organisations. The NHS London...
